Non-DLL3 messenger RNAs with seed-region complementarity

Non-DLL3 mRNAs with seed-region complementarity refers to a diverse group of messenger RNA (mRNA) molecules that are unintentionally targeted by RNA-based therapeutics designed for Delta-like ligand 3 (DLL3). This interaction occurs because these mRNAs contain sequences that match the 'seed region'—typically nucleotides 2 through 8—of the therapeutic small interfering RNA (siRNA) or antisense oligonucleotide (Jackson et al., 2003, Nature Biotechnology). Because the seed region is a primary determinant of RNA interference (RNAi) specificity, even partial complementarity can lead to the degradation or translational repression of these non-target transcripts (Birmingham et al., 2006, Nature Methods). While DLL3 is a key therapeutic target in small cell lung cancer and neuroendocrine tumors due to its role in Notch signaling (Saunders et al., 2015, Science Translational Medicine), the silencing of these off-target mRNAs can result in significant cellular toxicity or unintended phenotypic changes. Consequently, these mRNAs represent a major safety concern and a technical challenge in the development of highly specific genetic medicines. Computational modeling and experimental validation, such as RNA-seq, are essential to identify and minimize these interactions during the drug design process. Ensuring that these non-DLL3 mRNAs are not affected is critical for the clinical safety and specificity of DLL3-directed therapies.

Other names

Seed-matched off-targetsNon-target mRNAsRNAi off-target transcriptsSeed-region matched transcripts

Off-target gene silencing via seed-region complementarity leading to RISC-mediated mRNA degradation or translational inhibition.